In a publication Dr Alter and Dr Leonard Seeff made reference to a study conducted in Germany, which measured the impact of adding anti-HBc testing to the screening of a population already tested for ALT. It showed that recipients of anti-HBc positive blood had a five-fold greater risk of developing post-transfusion hepatitis than recipients of blood testing negative.